Loading organizations...
Terraflos Inc. has raised $8.0M across 1 funding round.
Key people at Terraflos Inc..
Terraflos Inc. has raised $8.0M in total across 1 funding round.
Terraflos Inc. is a consumer science company that integrates biotechnology and artificial intelligence to transform natural bioactives into functional products. It manages a full innovation cycle, from discovering novel species and active ingredients to developing evidence-based foods, nutritional supplements, and dermocosmetics, all optimized by AI. This approach maximizes plant power through scientific and technological advancements.
Founded in 2021 by Facundo Garreton, a former Argentinian congressman, the venture's insight centered on Latin America's largely unexplored biodiversity. Garreton envisioned enhancing human health, well-being, and longevity by converging science, nature, and technology.
Terraflos targets individuals prioritizing well-being, reaching them through its brands across supplements, foods, and SkinTech. The company's long-term vision is to drive evolution towards a future of enhanced well-being and longevity, leveraging proprietary AI systems like JEN to coordinate diverse teams and foster health innovation.
Terraflos Inc. has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in July 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2021 | $8M Seed | — | — | Announced |
Terraflos Inc. has raised $8.0M in total across 1 funding round.
# Terraflos Inc. — High-Level Overview
Terraflos is a biotechnology company that produces biocomponents using genetic information and plant stem cells to create active ingredients for cosmetic, nutraceutical, pharmaceutical, and food industries.[1] Founded by Facundo Garreton, the company prioritizes environmentally sustainable production methods as an alternative to conventional resource-extraction approaches.[1][2] Operating as a cannabis holding company incorporated in the British Virgin Islands with operations in Uruguay and Colombia,[3] Terraflos has raised $8 million in seed-stage funding and currently employs approximately 8 people.[1][4]
The company's core mission centers on enhancing health and wellbeing through products rooted in natural substances, science, and technology while maintaining ecological responsibility.[2] Rather than exploiting natural resources through conventional methodologies, Terraflos aims to satisfy food and medicine needs using non-conventional biotechnological approaches.[1] The company is actively exploring expansion opportunities into Argentina, Mexico, and Brazil.[1]
# Origin Story
Facundo Garreton, the founder, brings a multidisciplinary background combining systems analysis, investment management expertise, and leadership training from institutions including Singularity University and Chicago Booth.[2] His entrepreneurial track record spans multiple sectors—he previously founded InvertirOnline.com and ASEA, and has served as a Member of Congress, positioning him with both business acumen and policy experience.[2] This background shaped Terraflos's dual focus on technological innovation and environmental sustainability, reflecting Garreton's broader commitment to marrying progress with ecological responsibility.[2]
# Core Differentiators
# Role in the Broader Tech Landscape
Terraflos operates at the intersection of three significant trends: the biotech-driven ingredient economy, the cannabis legalization wave in Latin America, and the sustainability imperative reshaping consumer goods. As regulatory frameworks for cannabis and hemp-derived products mature across Latin America, companies with proprietary cultivation and extraction capabilities are positioned to capture value in both domestic and export markets. Terraflos's emphasis on non-conventional production methods aligns with broader industry shifts toward regenerative agriculture and circular economy principles, particularly relevant as cosmetic and pharmaceutical companies face pressure to source sustainable, traceable ingredients.
# Quick Take & Future Outlook
Terraflos is well-positioned to capitalize on Latin America's emerging biotech and cannabis sectors, though its current stage (seed funding, small team) suggests the company remains in early execution phases. The planned expansion into Argentina, Mexico, and Brazil indicates ambitions to become a regional biocomponent supplier rather than a single-market player.[1] Success will depend on scaling production capabilities, securing regulatory approvals across multiple jurisdictions, and converting its sustainability positioning into premium pricing power with enterprise customers. As the cosmetic and pharmaceutical industries increasingly demand sustainably sourced, scientifically validated bioactive ingredients, Terraflos's combination of biotechnological innovation and environmental stewardship could establish it as a differentiated supplier—provided it can move from proof-of-concept to commercial-scale production.
Key people at Terraflos Inc..
